NCT05114772View on ClinicalTrials.gov

Pre Procedural Biomarkers Might Predict Recurrent Atrial Fibrillation After Catheter Ablation

NACompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

July 1, 2021

Study Completion Date

August 1, 2021

Conditions
Atrial Fibrillation
Interventions
DIAGNOSTIC_TEST

Measuring Serum bio-markers

ELISA Estimation of Serum visfatin and tumor necrosis factor-alpha

Trial Locations (1)

Unknown

Tanta university, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT05114772 - Pre Procedural Biomarkers Might Predict Recurrent Atrial Fibrillation After Catheter Ablation | Biotech Hunter | Biotech Hunter